Literature DB >> 23916937

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.

Jannet A Eindhoven1, Annemien E van den Bosch, Titia P E Ruys, Petra Opić, Judith A A E Cuypers, Jackie S McGhie, Maarten Witsenburg, Eric Boersma, Jolien W Roos-Hesselink.   

Abstract

OBJECTIVES: The aim of this study was to determine the value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in adults with congenital heart disease (CHD) and investigate its relationship with ventricular function and exercise capacity.
BACKGROUND: NT-proBNP may detect early deterioration in cardiac function.
METHODS: In this cross-sectional study, extensive echocardiography, exercise testing, and NT-proBNP measurements were performed on the same day in consecutive adult patients with CHD.
RESULTS: In total, 475 patients were included in this study (mean age of 34 ± 12 years, 57% male, 90% New York Heart Association class I). The median NT-proBNP level was 15.1 pmol/l (interquartile range [IQR]: 7.1 to 31.3 pmol/l), and the NT-proBNP level was >14 pmol/l in 53% of patients. The highest NT-proBNP levels were observed in patients with Fontan circulation (36.1 pmol/l [IQR: 14.4 to 103.8 pmol/l]) and a systemic right ventricle (RV) (31.1 pmol/l [IQR: 21.8 to 56.0 pmol/l]), and the lowest values were seen in patients with aortic coarctation (7.3 pmol/l [IQR: 2.8 to 19.5 pmol/l]). NT-proBNP levels correlated with age (r = 0.39, p < 0.001) and were higher in women (median of 21.7 vs. 10.4 pmol/l; p < 0.001). In patients with aortic stenosis or aortic coarctation, NT-proBNP levels correlated with diastolic function parameters of E/E' ratio (r = 0.40, p < 0.001) and left atrial dimension (r = 0.36, p < 0.001). In patients with a systemic RV, NT-proBNP levels correlated with RV annulus diameter (r = 0.31, p = 0.024). In patients with tetralogy of Fallot, the strongest correlations were observed with left atrial dimension (r = 0.46, p < 0.001) and left ventricular ejection fraction (r = 0.37, p < 0.001). NT-proBNP levels were associated with exercise capacity (n = 198) (maximum workload: β = -0.08, p = 0.021) and peak oxygen uptake (β = -0.012, p = 0.011) in a multivariable regression model adjusted for age and sex.
CONCLUSIONS: NT-proBNP levels in adults with CHD clearly differ by diagnosis and are related to echocardiographic parameters and exercise capacity. Disease-specific correlations contribute to the understanding of the main hemodynamic problems per diagnosis. Follow-up data are needed to elucidate the additional prognostic value.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-dimensional echocardiography; ASO; AoS; CHD; CoA; FAC; IQR; LV; N-terminal pro-B-type natriuretic peptide; NT-proBNP; NYHA; New York Heart Association; RV; TGA; ToF; Vo(2max); aortic coarctation; aortic valvular stenosis; arterial switch operation; congenital heart disease; exercise test; fractional area change; interquartile range; left ventricle; maximal exercise capacity; maximal oxygen uptake; right ventricle; tetralogy of Fallot; transposition of the great arteries; workload(max)

Mesh:

Substances:

Year:  2013        PMID: 23916937     DOI: 10.1016/j.jacc.2013.07.019

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients.

Authors:  Elizabeth S Makil; Xinyu Tang; Elizabeth A Frazier; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2017-02-09       Impact factor: 1.655

2.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

3.  NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study.

Authors:  Annalisa Paolino; Tarique Hussain; Antonio Pavon; Maria Nieves Velasco; Sergio Uribe; Antonio Ordoñez; Israel Valverde
Journal:  Pediatr Cardiol       Date:  2016-11-21       Impact factor: 1.655

Review 4.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

5.  Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank.

Authors:  Alexander R Opotowsky; Brittani Loukas; Christina Ellervik; Lilamarie E Moko; Michael N Singh; Elizabeth I Landzberg; Eric B Rimm; Michael J Landzberg
Journal:  World J Pediatr Congenit Heart Surg       Date:  2016-11

6.  Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure.

Authors:  Catherine M Avitabile; Mary B Leonard; Jill L Brodsky; Kevin K Whitehead; Chitra Ravishankar; Meryl S Cohen; J William Gaynor; Jack Rychik; David J Goldberg
Journal:  Am J Cardiol       Date:  2015-01-06       Impact factor: 2.778

Review 7.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 8.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 9.  Cardiac biomarkers in children with congenital heart disease.

Authors:  Masaya Sugimoto; Seiko Kuwata; Clara Kurishima; Jeong Hye Kim; Yoich Iwamoto; Hideaki Senzaki
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

Review 10.  Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases.

Authors:  Patryk Leczycki; Maciej Banach; Marek Maciejewski; Agata Bielecka-Dabrowa
Journal:  Front Cardiovasc Med       Date:  2022-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.